Olimel N9e

Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin, the active ingredient in Olimel N9e, is a mixture of essential and non‑essential amino acids presented as a dietary supplement for oral use. It supports metabolic functions and protein synthesis in patients requiring nutritional support.

GNH USA supplies Olimel N9e as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

Olimel N9e provides amino acid supplementation for conditions where protein turnover is increased. - Post‑operative recovery: helps maintain nitrogen balance during healing. - Chronic kidney disease: supports nutritional status when dietary protein is restricted. - Severe burns or trauma: aids in rebuilding tissue protein stores. - Malnutrition in elderly patients: assists in preserving lean body mass. - Metabolic disorders affecting amino acid utilization: contributes to overall amino acid pool.

Amino acid mixtures are generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild gastrointestinal discomfort. - Abdominal bloating: sensation of fullness or gas. - Diarrhoea: loose stools, usually transient. - Metallic taste: temporary alteration in mouthfeel. - Headache: mild, self‑limiting. - Skin redness at oral mucosa: mild irritation.

Serious or Rare Side Effects: - Hypersensitivity reaction: rash, itching, swelling, or anaphylaxis. - Hyperammonemia: elevated blood ammonia in patients with severe liver dysfunction. - Metabolic acidosis: rare disturbance of acid‑base balance. - Severe gastrointestinal upset: persistent vomiting or severe diarrhoea. - Renal impairment exacerbation: worsening kidney function in susceptible individuals.

When prescribing Olimel N9e, consider patient‑specific factors and monitor for adverse events. - Renal function: assess baseline creatinine and adjust use in severe impairment. - Hepatic function: avoid in patients with uncontrolled liver disease due to ammonia risk. - Pregnancy and lactation: use only if clearly needed; limited safety data are available. - Concomitant nutrition therapy: coordinate with dietitian to avoid excess protein intake. - Allergies: verify no known hypersensitivity to any listed amino acids. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Amino acid supplements can influence the pharmacokinetics of certain medications.

Major Interactions (Avoid): - Levodopa: high‑dose amino acids may reduce absorption and efficacy. - Anticonvulsants (e.g., valproate): may increase risk of hyperammonemia.

Moderate Interactions (Monitor Closely): - Insulin and oral hypoglycaics: amino acids can affect glucose metabolism, requiring dose adjustments. - Thyroid hormone replacement: may alter absorption, necessitating monitoring of thyroid function tests.",

"metatitle": "Olimel N9e Amino Acid Blend (Valine‑Alanine‑Arginine…) | GNH USA",

"metadesc": "GNH USA supplies Olimel N9e (amino acid blend), a nutritional supplement for post‑operative, renal and trauma care. Request a quote for global supply.",

"keywords": "Olimel N9e amino acid supplement, essential amino acids for clinical nutrition, post‑operative protein support, renal nutrition supplement, trauma amino acid therapy, GNH USA pharmaceutical supply, EU‑origin amino acid blend, clinical nutrition product",

"faqs": [ {"q": "What is Olimel N9e used for?", "a": "Olimel N9e is an oral amino‑acid supplement designed to provide essential and non‑essential amino acids for patients who need additional nutritional support, such as after surgery, during chronic kidney disease, severe burns, or other conditions that increase protein turnover."}, {"q": "How does the amino‑acid blend in Olimel N9e work?", "a": "The blend supplies the building blocks required for protein synthesis and supports the mTOR pathway, helping cells repair and grow while maintaining nitrogen balance, which is especially important when dietary protein intake is limited or metabolic demand is high."}, {"q": "What is the usual dose of Olimel N9e?", "a": "The dose of Olimel N9e is determined by the prescribing clinician based on the individual’s nutritional needs, clinical condition, and laboratory parameters. No fixed regimen is provided here; the prescriber sets the appropriate amount."}, {"q": "Is Olimel N9e safe during pregnancy or breastfeeding?", "a": "Safety data are limited, so Olimel N9e should only be used during pregnancy or lactation when the potential benefit outweighs any possible risk, and under close medical supervision."}, {"q": "How do I order Olimel N9e from GNH USA?", "a": "Submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation."}, {"q": "How does Olimel N9e compare with other amino‑acid products?", "a": "Olimel N9e offers a broad spectrum of ten amino acids in a single formulation, providing a more comprehensive profile than many single‑amino‑acid supplements, which can simplify dosing and improve overall nitrogen balance in clinical nutrition protocols."}, {"q": "How should Olimel N9e be stored and handled?", "a": "Store the product at ambient temperature, below 25 °C, in its original packaging. Protect it from moisture, heat and direct sunlight to maintain stability."}, {"q": "How is Olimel N9e administered?", "a": "The supplement is taken orally, usually dissolved in water or another suitable liquid, as directed by the healthcare professional overseeing the patient’s nutrition plan."}, {"w": "What are the most serious risks associated with Olimel N9e?", "a": "Serious risks include hypersensitivity reactions such as rash, itching, swelling or anaphylaxis, as well as rare metabolic complications like hyperammonemia or metabolic acidosis, particularly in patients with severe liver or kidney disease."}, {"q": "Who should not use    """""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""